Schedule 13G ownership disclosure

CRISPR Therapeutics AG

Common Stock · CUSIP: H17182108

Event date: 2025-03-31

Filing-level shares
6,334,142.00
Percent of class
7.4%
  • Capital International Investors

    Shares: 6,334,142.00 · Class: 7.4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001562230-25-000068
Form type
SCHEDULE 13G/A
Filer
CRISPR Therapeutics AG
CIK
CIK 1674416
Filed
May 13, 2025
Reporting period
Mar 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub